$CYTH
Cyclo Therapeutics, Inc.

2019 Q3 Form 10-Q Financial Statement

#000143774919016546 Filed on August 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q4
Revenue $285.9K $273.1K $240.0K
YoY Change 27.37% -21.84% 41.18%
Cost Of Revenue $25.97K $16.31K $20.00K
YoY Change 99.06% -69.82% 0.0%
Gross Profit $259.9K $256.8K $220.0K
YoY Change 22.94% -13.06% 46.67%
Gross Profit Margin 90.92% 94.03% 91.67%
Selling, General & Admin $940.0K $840.0K $610.0K
YoY Change 84.31% 13.51% -17.57%
% of Gross Profit 361.62% 327.12% 277.27%
Research & Development $941.5K $786.8K $970.0K
YoY Change 93.85% -6.82% 24.36%
% of Gross Profit 362.21% 306.41% 440.91%
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change -100.0%
% of Gross Profit 0.0% 0.0% 0.0%
Operating Expenses $941.5K $786.8K $1.580M
YoY Change 93.85% -6.82% 3.27%
Operating Profit -$1.629M -$1.370M -$1.360M
YoY Change 106.22% 5.83% -1.45%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.625M -$1.368M -$1.370M
YoY Change 106.44% 6.11% -0.72%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.625M -$1.368M -$1.370M
YoY Change 106.44% 6.11% -0.72%
Net Earnings / Revenue -568.47% -500.93% -570.83%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.347M -$1.356M -$1.557M
COMMON SHARES
Basic Shares Outstanding 121.0M 91.26M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.990M $6.610M $2.220M
YoY Change 345.54% 329.22% 74.8%
Cash & Equivalents $4.994M $6.608M $2.217M
Short-Term Investments
Other Short-Term Assets $240.0K $28.49K $18.19K
YoY Change 435.44% -36.44% -70.11%
Inventory $384.1K $397.6K $416.5K
Prepaid Expenses
Receivables $35.74K $154.1K $80.04K
Other Receivables $30.00K $40.00K $40.00K
Total Short-Term Assets $5.690M $7.403M $2.770M
YoY Change 232.55% 249.1% 46.09%
LONG-TERM ASSETS
Property, Plant & Equipment $15.63K $16.93K $18.57K
YoY Change -21.11% -24.25% -27.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $178.2K
YoY Change
Total Long-Term Assets $172.6K $187.6K $148.2K
YoY Change 7.79% 9.25% -23.13%
TOTAL ASSETS
Total Short-Term Assets $5.690M $7.403M $2.770M
Total Long-Term Assets $172.6K $187.6K $148.2K
Total Assets $5.862M $7.591M $2.918M
YoY Change 213.31% 231.13% 39.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.320M $2.690M $1.930M
YoY Change 40.61% 108.53% 105.32%
Accrued Expenses $10.00K $10.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.337M $2.705M $1.925M
YoY Change 41.62% 109.68% 104.16%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $40.00K $50.00K
YoY Change
Total Long-Term Liabilities $40.00K $50.00K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.337M $2.705M $1.925M
Total Long-Term Liabilities $40.00K $50.00K $0.00
Total Liabilities $2.380M $2.750M $1.930M
YoY Change 44.24% 113.18% 105.32%
SHAREHOLDERS EQUITY
Retained Earnings -$22.49M -$20.86M -$17.59M
YoY Change 38.61% 35.15% 31.91%
Common Stock $12.11K $12.05K $9.075K
YoY Change 38.83% 38.16% 24.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.483M $4.840M $992.5K
YoY Change
Total Liabilities & Shareholders Equity $5.862M $7.591M $2.918M
YoY Change 213.31% 231.13% 39.7%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q4
OPERATING ACTIVITIES
Net Income -$1.625M -$1.368M -$1.370M
YoY Change 106.44% 6.11% -0.72%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Operating Activities -$1.620M -$1.520M -$1.060M
YoY Change 285.71% 56.7% 8.16%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $10.00K $10.00K $10.00K
YoY Change 0.0% -50.0% 0.0%
Cash From Investing Activities $10.00K $10.00K $0.00
YoY Change 0.0% -50.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 7.000M 2.140M
YoY Change 270.37% 137.78%
NET CHANGE
Cash From Operating Activities -1.620M -1.520M -1.060M
Cash From Investing Activities 10.00K 10.00K 0.000
Cash From Financing Activities 0.000 7.000M 2.140M
Net Change In Cash -1.610M 5.490M 1.080M
YoY Change 292.68% 484.04% -1642.86%
FREE CASH FLOW
Cash From Operating Activities -$1.620M -$1.520M -$1.060M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$1.620M -$1.520M -$1.060M
YoY Change 285.71% 56.7% 8.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
ctdh Freight And Shipping
FreightAndShipping
2450
CY2018Q2 ctdh Freight And Shipping
FreightAndShipping
1643
CY2019Q1 ctdh Equity Impact Of Cash Received From Stock Subscription
EquityImpactOfCashReceivedFromStockSubscription
130062
CY2019Q2 ctdh Freight And Shipping
FreightAndShipping
1016
ctdh Freight And Shipping
FreightAndShipping
3525
CY2016Q1 ctdh Mortgage Loans On Real Estate Monthly Payment
MortgageLoansOnRealEstateMonthlyPayment
3653
CY2019Q2 ctdh Operating Lease Right Of Usse Asset Amortization
OperatingLeaseRightOfUsseAssetAmortization
8502
CY2019Q2 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
111144
CY2018Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
129674
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7119662
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
67930
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13760
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27950
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
80044
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25687834
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18701211
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
525510
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
396105
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36540
ctdh Proceeds From Collection Of Stock Subscription
ProceedsFromCollectionOfStockSubscription
130062
ctdh Proceeds From Collection Of Stock Subscription
ProceedsFromCollectionOfStockSubscription
ctdh Proceeds From Sale Of Common Stock And Warrants Net Of Issue Costs
ProceedsFromSaleOfCommonStockAndWarrantsNetOfIssueCosts
6989600
ctdh Proceeds From Sale Of Common Stock And Warrants Net Of Issue Costs
ProceedsFromSaleOfCommonStockAndWarrantsNetOfIssueCosts
1960000
CY2019Q2 ctdh Repairs And Maintenance
RepairsAndMaintenance
1299
CY2018Q2 ctdh Repairs And Maintenance
RepairsAndMaintenance
1271
ctdh Repairs And Maintenance
RepairsAndMaintenance
2983
ctdh Repairs And Maintenance
RepairsAndMaintenance
1271
ctdh Sharebased Compensation Employees
SharebasedCompensationEmployees
13100
ctdh Sharebased Compensation Employees
SharebasedCompensationEmployees
6500
ctdh Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
54830
ctdh Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
21450
dei Document Type
DocumentType
10-Q
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
121034463
dei Entity Shell Company
EntityShellCompany
false
CY2016Q1 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
265000
CY2016Q1 srt Mortgage Loans On Real Estate Interest Rate
MortgageLoansOnRealEstateInterestRate
0.0425
CY2019Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
37439
CY2018Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
37439
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2690632
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1925332
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
154110
CY2019Q2 us-gaap Assets
Assets
7591024
CY2018Q4 us-gaap Assets
Assets
2917856
CY2019Q2 us-gaap Assets Current
AssetsCurrent
7403435
CY2018Q4 us-gaap Assets Current
AssetsCurrent
2769611
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120529324
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90759324
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
120529324
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90759324
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
12052
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
9075
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
60383
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6607613
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2217412
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1270973
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1541030
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4390201
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
270057
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
CY2018Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
130062
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16309
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
54040
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
36859
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
77712
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
1643379
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
1644155
us-gaap Costs And Expenses
CostsAndExpenses
3771995
us-gaap Costs And Expenses
CostsAndExpenses
2656600
us-gaap Depreciation
Depreciation
2969
us-gaap Depreciation
Depreciation
5026
CY2019Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
1485
CY2018Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2526
us-gaap Depreciation Nonproduction
DepreciationNonproduction
2969
us-gaap Depreciation Nonproduction
DepreciationNonproduction
5026
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1289229
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3272177
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2102173
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1368011
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
697370
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
318038
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
74066
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34567
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-18947
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-63635
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
10304
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-16023
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-864
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
178200
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
CY2019Q2 us-gaap Inventory Net
InventoryNet
397584
CY2018Q4 us-gaap Inventory Net
InventoryNet
416531
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
39700
CY2019Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
39700
CY2019Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2273
CY2018Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
5511
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
5897
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
6943
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7591024
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2917856
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2704814
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1925332
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-1368011
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1960000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17206
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16125
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2746667
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1706068
us-gaap Net Income Loss
NetIncomeLoss
-3272177
us-gaap Net Income Loss
NetIncomeLoss
-2102173
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-812944
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-1289229
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1904166
CY2019Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
31611
CY2018Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
27233
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
64696
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
43016
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1370284
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1294740
us-gaap Operating Income Loss
OperatingIncomeLoss
-3278074
us-gaap Operating Income Loss
OperatingIncomeLoss
-2109116
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
8045
us-gaap Operating Lease Expense
OperatingLeaseExpense
11376
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14182
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46201
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
59519
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q2 us-gaap Other Assets Current
OtherAssetsCurrent
28489
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
18185
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
178200
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
CY2019Q2 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
247495
CY2018Q2 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
127982
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
350137
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
175849
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-18530
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-17759
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1324
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1634
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
74983
CY2016Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
10000
CY2019Q2 us-gaap Professional Fees
ProfessionalFees
246276
CY2018Q2 us-gaap Professional Fees
ProfessionalFees
297308
us-gaap Professional Fees
ProfessionalFees
461251
us-gaap Professional Fees
ProfessionalFees
531284
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16926
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18571
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
786811
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
844376
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2129574
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1253574
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20859877
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17587700
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
273095
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
349415
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
493921
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
547484
CY2019Q2 us-gaap Salaries And Wages
SalariesAndWages
311077
CY2018Q2 us-gaap Salaries And Wages
SalariesAndWages
287776
us-gaap Salaries And Wages
SalariesAndWages
721076
us-gaap Salaries And Wages
SalariesAndWages
565343
CY2018Q2 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
1960000
CY2018Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6989600
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
4840009
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
992524
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
1145618
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
332674
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
1003445
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-781580
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">(n) USE OF ESTIMATES&#x2013;&#x2013;The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes, including contingencies. Although management bases its estimates on historical experience and assumptions that are believed to be reasonable under the circumstances, actual results could significantly differ from these estimates.</div></div></div></div></div></div></div></div>
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
101013435
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78853583
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
95886380
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
75926472

Files In Submission

Name View Source Status
0001437749-19-016546-index-headers.html Edgar Link pending
0001437749-19-016546-index.html Edgar Link pending
0001437749-19-016546.txt Edgar Link pending
0001437749-19-016546-xbrl.zip Edgar Link pending
ctdh-20190630.xml Edgar Link completed
ctdh-20190630.xsd Edgar Link pending
ctdh-20190630_cal.xml Edgar Link unprocessable
ctdh-20190630_def.xml Edgar Link unprocessable
ctdh-20190630_lab.xml Edgar Link unprocessable
ctdh-20190630_pre.xml Edgar Link unprocessable
ctdh20190630_10q.htm Edgar Link pending
ex_154402.htm Edgar Link pending
ex_154403.htm Edgar Link pending
ex_154404.htm Edgar Link pending
ex_154405.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending